BioSpace News Archive

Drug Development

Exelixis, Inc. and Bristol-Myers Squibb Company (JOBS) Report Phase 2 Data for XL184 in Patients with Previously Treated Glioblastoma Multiforme; Results Not up Expectations

June 1, 2009
·
7 min read
Biotech Beach

Applied Biosystems/MDS Analytical Technologies Launches New Mass Spectrometry Tools to Advance Public Health and Safety

June 1, 2009
·
1 min read
Drug Development

Peregrine Pharmaceuticals, Inc. Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 American Society of Clinical Oncology Annual Meeting

June 1, 2009
·
8 min read
Choice Hotels International to Present at Goldman Sachs Lodging, Gaming, Restaurant and Leisure Conference on June 2

June 1, 2009
·
1 min read
Drug Development

Ascenta Therapeutics Inc. Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 American Society of Clinical Oncology Annual Meeting

June 1, 2009
·
6 min read
Does Biltmore’s La Bistecca Count as a New Restaurant?

June 1, 2009
·
1 min read
Drug Development

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer

June 1, 2009
·
7 min read
Bruker BioSpin Corporation Announces Avance 1000, the World’s First 1 Gigahertz NMR Spectrometer

June 1, 2009
·
1 min read
Drug Development

Mersana Therapeutics, Inc. Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors

June 1, 2009
·
3 min read
Drug Development

Can-Fite BioPharma Completed Patient Enrollment for the Phase II Trial in Psoriasis With CF101

June 1, 2009
·
1 min read